Events & Training for December 2015
Cell Therapy Manufacturing & Gene Therapy Congress
02 December 2015 - 03 December 2015
Informa Life Sciences is offering free press passes for its Cell Therapy Manufacturing & Gene Therapy Congress. Together with ISCT, Informa will be bringing together Cell and Gene Therapy industry experts to discuss the critical issues facing the development, scale-up and manufacture of cell-based and gene therapies, all in line with international regulations, from scale-up to scale-out, characterisation to process release, freeze/ thaw to needle-to-needle logistics.
Sheraton Brussels Airport Hotel, Belgium
http://www.informa-ls.com/event/celltherapy15?xtssot=0
Trends in Medicinal Chemistry
03 December 2015
Sir Simon Campbell CBE FRS, UK
“Science, Art and Drug Discovery - A Personal Perspective”
Dr Magnus Walter, Lilly, UK
“Changing Times and Changing Paradigms in Drug Discovery – a Lilly Perspective”
Dr Chris Selway, Cyclofluidics, UK
“Applications of Flow Chemistry Technology in Drug Discovery and Development”
Dr Mike Hann, GSK, UK
“Moving beyond Molecular Obesity and Potency as addictions in Drug Discovery”
Dr. Gary Tresadern, Janssen, Belgium
“Application of drugability indices within Janssen”
Dr. Yen Choo, Progenitor Therapeutics, UK (TBC)
“Regulation of stem cells with small molecules“
Prof. Stephan Sieber, Munich, Germany
“Natural products and their cellular targets”
National Heart and Lung Institute, Dovehouse Street London SW3 6LY
http://www.smr.org.uk/
#2 Natural Products Conference
04 December 2015 - 07 December 2015
Working with a natural product compound has always been a challenge. From extraction, purification, isolation, structure characterization and chemical synthesis, natural product research has faced many pitfalls and hurdles that can be overcome by an intelligent use of analytical technology. This conference will focus on key areas of natural product research.
Hilton Budapest, Budapest, Hungary
http://www.fusion-conferences.com/conference33.php?utm_source=o&utm_medium=e&utm_campaign=m204
Target Validation using Genomics and Informatics
08 December 2015 - 10 December 2015
Wellcome Trust Scientific Conferences in association with EMBL is pleased to announce this new conference on Target Validation using Genomics and Informatics. In the past few years, exceptional progress has been made in the application of genetics- and genomics-based technologies in biomedical research. There are currently thousands of DNA variants that are robustly associated with clinically relevant human traits. Although these should provide a rich source of molecular starting points for drug discovery, and a deeper understanding of their role in human physiology, the translation of these data from large-scale projects has been slow to influence the selection and validation of new targets in drug discovery and development programmes.This meeting will bring together researchers based in academia and industry to focus on the opportunities and challenges for genomics in drug discovery. Epidemiology, molecular biology and computational approaches will be covered with a focus on contributions these methods can offer to the development of new therapies to treat patients.
Wellcome Trust Genome Campus, Hinxton, Cambridge, UK
https://registration.hinxton.wellcome.ac.uk/display_info.asp?id=522